UBS Group’s Global X Scientific Beta US ETF SCIU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-4,857
| Closed | -$151K | – | 8765 |
|
|
2020
Q2 | $151K | Buy |
4,857
+755
| +18% | +$22.9K | ﹤0.01% | 5003 |
|
|
2020
Q1 | $110K | Sell |
4,102
-260
| -6% | -$8.56K | ﹤0.01% | 5215 |
|
|
2019
Q4 | $153K | Buy |
4,362
+1,097
| +34% | +$37.5K | ﹤0.01% | 5768 |
|
|
2019
Q3 | $110K | Buy |
3,265
+344
| +12% | +$11.4K | ﹤0.01% | 5718 |
|
|
2019
Q2 | $96K | Buy |
2,921
+1,025
| +54% | +$33.1K | ﹤0.01% | 5404 |
|
|
2019
Q1 | $60K | Sell |
1,896
-1
| -0.1% | -$30 | ﹤0.01% | 5428 |
|
|
2018
Q4 | $53K | Sell |
1,897
-842
| -31% | -$25.9K | ﹤0.01% | 6050 |
|
|
2018
Q3 | $91K | Buy |
2,739
+1,527
| +126% | +$49.9K | ﹤0.01% | 5677 |
|
|
2018
Q2 | $39K | Sell |
1,212
-681
| -36% | -$21.4K | ﹤0.01% | 6200 |
|
|
2018
Q1 | $58K | Buy |
1,893
+525
| +38% | +$16.5K | ﹤0.01% | 5602 |
|
|
2017
Q4 | $42K | Buy |
1,368
+580
| +74% | +$17.7K | ﹤0.01% | 5988 |
|
|
2017
Q3 | $23K | Buy |
+788
| New | +$22.9K | ﹤0.01% | 6361 |
|
|
2016
Q3 | – | Sell |
-146
| Closed | -$4K | – | 8083 |
|
|
2016
Q2 | $4K | Sell |
146
-54
| -27% | -$1.35K | ﹤0.01% | 7264 |
|
|
2016
Q1 | $5K | Sell |
200
-1,050
| -84% | -$24.4K | ﹤0.01% | 7029 |
|
|
2015
Q4 | $30K | Buy |
+1,250
| New | +$30.4K | ﹤0.01% | 6337 |
|
UBS Group's SCIU Position: Q3 2020 in Review
UBS Group sold out of Global X Scientific Beta US ETF (SCIU) in Q3 2020, closing a stake of 4,857 shares — an estimated $151K sold.
UBS Group first reported a position in SCIU in Q4 2015 and held it in 15 quarters. The position peaked at $153K in Q4 2019. 0 funds tracked by Wall St. Rank hold SCIU as of Q3 2020.
- UBS Group reported no remaining Global X Scientific Beta US ETF position as of Q3 2020 after selling out during the quarter.
- UBS Group sold 4,857 Global X Scientific Beta US ETF shares in Q3 2020, an estimated $151K.
- UBS Group first reported a position in Global X Scientific Beta US ETF in Q4 2015 and held it in 15 quarters.
- UBS Group's Global X Scientific Beta US ETF position peaked at $153K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Global X Scientific Beta US ETF as of Q3 2020.
Based on UBS Group's 13F filing for Q3 2020, filed 12 Nov 2020.